chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Cough, Dizziness, Dry mouth, Eating disorder
Clinical narrative: She is terribly sick; Stomach ache; head is all foggy today; headache; feeling dizzy; mouth is very dry; cannot seem to eat any food; feels miserable; Face flushed and hot; Coughing; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 19Oct2021 13:15 (Lot number: EN629) at the age of 75 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First dose of the Pfizer COVID vaccine was on 16Mar2021 with Lot ER8732, Unknown expiration,Unknown anatomical location), administration date: 16Mar2021, when the patient was 74 years old, for Covid-19 immunization; Bnt162b2 (Second dose was on 06Apr2021 with Lot ER8732, Unknown expiration,Unknown anatomical location), administration date: 06Apr2021, when the patient was 74 years old, for Covid-19 immunization. The following information was reported: ILLNESS (non-serious) with onset 19Oct2021, outcome "not recovered", described as "She is terribly sick"; ABDOMINAL PAIN UPPER (non-serious) with onset 19Oct2021, outcome "not recovered", described as "Stomach ache"; FEELING ABNORMAL (non-serious) with onset 19Oct2021, outcome "not recovered", described as "head is all foggy today"; HEADACHE (non-serious) with onset 19Oct2021, outcome "not recovered", described as "headache"; DIZZINESS (non-serious) with onset 19Oct2021, outcome "not recovered", described as "feeling dizzy"; DRY MOUTH (non-serious) with onset 19Oct2021, outcome "not recovered", described as "mouth is very dry"; EATING DISORDER (non-serious) with onset 19Oct2021, outcome "not recovered", described as "cannot seem to eat any food"; FEELING ABNORMAL (non-serious) with onset 19Oct2021, outcome "not recovered", described as "feels miserable"; FLUSHING (non-serious) with onset 19Oct2021, outcome "not recovered", described as "Face flushed and hot"; COUGH (non-serious) with onset 19Oct2021, outcome "not recovered", described as "Coughing". No follow-up attempts are possible. No further information is expected.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Flushing, Headache, Illness
Clinical narrative: She is terribly sick; Stomach ache; head is all foggy today; headache; feeling dizzy; mouth is very dry; cannot seem to eat any food; feels miserable; Face flushed and hot; Coughing; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 19Oct2021 13:15 (Lot number: EN629) at the age of 75 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First dose of the Pfizer COVID vaccine was on 16Mar2021 with Lot ER8732, Unknown expiration,Unknown anatomical location), administration date: 16Mar2021, when the patient was 74 years old, for Covid-19 immunization; Bnt162b2 (Second dose was on 06Apr2021 with Lot ER8732, Unknown expiration,Unknown anatomical location), administration date: 06Apr2021, when the patient was 74 years old, for Covid-19 immunization. The following information was reported: ILLNESS (non-serious) with onset 19Oct2021, outcome "not recovered", described as "She is terribly sick"; ABDOMINAL PAIN UPPER (non-serious) with onset 19Oct2021, outcome "not recovered", described as "Stomach ache"; FEELING ABNORMAL (non-serious) with onset 19Oct2021, outcome "not recovered", described as "head is all foggy today"; HEADACHE (non-serious) with onset 19Oct2021, outcome "not recovered", described as "headache"; DIZZINESS (non-serious) with onset 19Oct2021, outcome "not recovered", described as "feeling dizzy"; DRY MOUTH (non-serious) with onset 19Oct2021, outcome "not recovered", described as "mouth is very dry"; EATING DISORDER (non-serious) with onset 19Oct2021, outcome "not recovered", described as "cannot seem to eat any food"; FEELING ABNORMAL (non-serious) with onset 19Oct2021, outcome "not recovered", described as "feels miserable"; FLUSHING (non-serious) with onset 19Oct2021, outcome "not recovered", described as "Face flushed and hot"; COUGH (non-serious) with onset 19Oct2021, outcome "not recovered", described as "Coughing". No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, Nasal congestion
Clinical narrative: fatigue; cough; nasal congestion; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  An 85-year-old female patient received bnt162b2 (COMIRNATY), administration date 17Oct2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunization.   The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose1, single), for Covid-19 immunization; Bnt162b2 (Dose 2, single), administration date: Mar2021, for Covid-19 immunization.  The following information was reported: FATIGUE (non-serious) with onset 18Oct2021, outcome "recovering", described as "fatigue"; COUGH (non-serious) with onset 18Oct2021, outcome "recovering", described as "cough"; NASAL CONGESTION (non-serious) with onset 18Oct2021, outcome "recovering", described as "nasal congestion".  Additional information: The symptoms were improving. She does not recall having these symptoms after the first 2 Pfizer-BioNTech COVID-19 vaccine doses (2nd dose was around 7 months ago)  No follow-up attempts are possible. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Joint swelling, Lymphadenopathy, Pain, Rash
Clinical narrative: Uncontrol able shaking all over; Tired; rash on arms & legs; swollen lymph node under left arm; swollen joints and pain x 2 weeks; swollen joints and pain x 2 weeks; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 58 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 29Jan2021 08:45 (Lot number: EL3247) at the age of 57 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "hypothyroid" (unspecified if ongoing); "migraines" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: TREMOR (non-serious) with onset Jan2021, outcome "recovered" (2021), described as "Uncontrol able shaking all over"; FATIGUE (non-serious) with onset Jan2021, outcome "recovered" (2021), described as "Tired"; RASH (non-serious) with onset Jan2021, outcome "recovered" (2021), described as "rash on arms & legs"; LYMPHADENOPATHY (non-serious) with onset Jan2021, outcome "recovered" (2021), described as "swollen lymph node under left arm"; JOINT SWELLING (non-serious), PAIN (non-serious) all with onset Jan2021, outcome "recovered" (2021) and all described as "swollen joints and pain x 2 weeks". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of tremor, fatigue, rash, lymphadenopathy, joint swelling, pain.  Additional information: patient had no known allergies. Adverse events (Uncontrol able shaking all over, Tired, rash on arms & legs, swollen lymph node under left arm, swollen joints and pain x 2 weeks) start time: 09:30 PM. Facility where the most recent COVID-19 vaccine administered was Hospital. the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination the patient tested for COVID-19. Patient had also received second dose on 09Feb2021 at 09:00, lot number:EL9267 via Intramuscular route in the left arm.  No follow-up attempts are possible. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Tremor
Clinical narrative: Uncontrol able shaking all over; Tired; rash on arms & legs; swollen lymph node under left arm; swollen joints and pain x 2 weeks; swollen joints and pain x 2 weeks; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 58 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 29Jan2021 08:45 (Lot number: EL3247) at the age of 57 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "hypothyroid" (unspecified if ongoing); "migraines" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: TREMOR (non-serious) with onset Jan2021, outcome "recovered" (2021), described as "Uncontrol able shaking all over"; FATIGUE (non-serious) with onset Jan2021, outcome "recovered" (2021), described as "Tired"; RASH (non-serious) with onset Jan2021, outcome "recovered" (2021), described as "rash on arms & legs"; LYMPHADENOPATHY (non-serious) with onset Jan2021, outcome "recovered" (2021), described as "swollen lymph node under left arm"; JOINT SWELLING (non-serious), PAIN (non-serious) all with onset Jan2021, outcome "recovered" (2021) and all described as "swollen joints and pain x 2 weeks". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of tremor, fatigue, rash, lymphadenopathy, joint swelling, pain.  Additional information: patient had no known allergies. Adverse events (Uncontrol able shaking all over, Tired, rash on arms & legs, swollen lymph node under left arm, swollen joints and pain x 2 weeks) start time: 09:30 PM. Facility where the most recent COVID-19 vaccine administered was Hospital. the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination the patient tested for COVID-19. Patient had also received second dose on 09Feb2021 at 09:00, lot number:EL9267 via Intramuscular route in the left arm.  No follow-up attempts are possible. No further information is expected.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Fever of 102.4 approx. 24 hours of receiving booster; Persistent headache for 5 days from booster; This is a spontaneous report received from contactable reporter(s) (Physician). The reporter is the patient.  A 57 year-old male patient received bnt162b2 (BNT162B2), administration date 15Oct2021 (Batch/Lot number: unknown) at the age of 57 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion), for Covid-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion), for Covid-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 16Oct2021, outcome "recovered", described as "Fever of 102.4 approx. 24 hours of receiving booster"; HEADACHE (non-serious) with onset 16Oct2021, outcome "recovered" (21Oct2021), described as "Persistent headache for 5 days from booster". Therapeutic measures were not taken as a result of pyrexia, headache.  Additional information: No known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient has not been tested for COVID-19. Adverse event resulted in none of the above.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Burning sensation, Chest discomfort, Dry mouth, Dyspnoea
Clinical narrative: tightness in chest difficult to take a deep breath; Burning in upper arm; very sore for 2 full days; dry mouth for 2 weeks; high anxiety level; tightness in chest difficult to take a deep breath; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 01Oct2021 19:15 (Lot number: 3013586) at the age of 56 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "High Blood pressure" (unspecified if ongoing); "cholesterol" (unspecified if ongoing). Concomitant medication(s) included: LOSARTIN; ROSUVASTATIN. Past drug history included: Percocet, reaction(s): "known allergies : Percocet". The following information was reported: DYSPNOEA (non-serious), CHEST DISCOMFORT (non-serious) all with onset 02Oct2021 05:00, outcome "recovered with sequelae" and all described as "tightness in chest difficult to take a deep breath"; BURNING SENSATION (non-serious) with onset 02Oct2021 05:00, outcome "recovered with sequelae", described as "Burning in upper arm"; PAIN (non-serious) with onset 02Oct2021 05:00, outcome "recovered with sequelae", described as "very sore for 2 full days"; DRY MOUTH (non-serious) with onset 02Oct2021 05:00, outcome "recovered with sequelae", described as "dry mouth for 2 weeks"; ANXIETY (non-serious) with onset 02Oct2021 05:00, outcome "recovered with sequelae", described as "high anxiety level". Therapeutic measures were not taken as a result of dyspnoea, burning sensation, pain, dry mouth, anxiety, chest discomfort.  Additional information: Patient did not receive any other vaccine in four weeks. Did not experience COVID prior vaccination, not tested COVID post vaccination and no treatment received.  No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: tightness in chest difficult to take a deep breath; Burning in upper arm; very sore for 2 full days; dry mouth for 2 weeks; high anxiety level; tightness in chest difficult to take a deep breath; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 01Oct2021 19:15 (Lot number: 3013586) at the age of 56 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "High Blood pressure" (unspecified if ongoing); "cholesterol" (unspecified if ongoing). Concomitant medication(s) included: LOSARTIN; ROSUVASTATIN. Past drug history included: Percocet, reaction(s): "known allergies : Percocet". The following information was reported: DYSPNOEA (non-serious), CHEST DISCOMFORT (non-serious) all with onset 02Oct2021 05:00, outcome "recovered with sequelae" and all described as "tightness in chest difficult to take a deep breath"; BURNING SENSATION (non-serious) with onset 02Oct2021 05:00, outcome "recovered with sequelae", described as "Burning in upper arm"; PAIN (non-serious) with onset 02Oct2021 05:00, outcome "recovered with sequelae", described as "very sore for 2 full days"; DRY MOUTH (non-serious) with onset 02Oct2021 05:00, outcome "recovered with sequelae", described as "dry mouth for 2 weeks"; ANXIETY (non-serious) with onset 02Oct2021 05:00, outcome "recovered with sequelae", described as "high anxiety level". Therapeutic measures were not taken as a result of dyspnoea, burning sensation, pain, dry mouth, anxiety, chest discomfort.  Additional information: Patient did not receive any other vaccine in four weeks. Did not experience COVID prior vaccination, not tested COVID post vaccination and no treatment received.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Asthma, Fatigue, Feeling abnormal, Pain
Clinical narrative: Body aches; Fever; Fatigue; Joint pain; Rash on right hand (injection in left arm); Immediate pain at injection site, lasting 4 days; Feeling brain fog; Asthma; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administered in arm left, administration date 13Oct2021 (Lot number: FE3590) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: Covid long-hauler, having been diagnosed in Mar202. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 Immunization; Bnt162b2 (Dose: 2), for COVID-19 Immunization. The following information was reported: INJECTION SITE PAIN (non-serious) with onset 13Oct2021, outcome "recovered" (Oct2021), described as "Immediate pain at injection site, lasting 4 days"; PAIN (non-serious) with onset 15Oct2021, outcome "recovered" (Oct2021), described as "Body aches"; PYREXIA (non-serious) with onset 15Oct2021, outcome "recovered" (Oct2021), described as "Fever"; FATIGUE (non-serious) with onset 15Oct2021, outcome "recovered" (Oct2021), described as "Fatigue"; ARTHRALGIA (non-serious) with onset 15Oct2021, outcome "recovered" (Oct2021), described as "Joint pain"; RASH (non-serious) with onset 15Oct2021, outcome "recovered" (Oct2021), described as "Rash on right hand (injection in left arm)"; FEELING ABNORMAL (non-serious) with onset 2021, outcome "unknown", described as "Feeling brain fog"; ASTHMA (non-serious) with onset 2021, outcome "unknown", described as "Asthma". Therapeutic measures were taken as a result of asthma.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia, Rash, Vaccination site pain
Clinical narrative: Body aches; Fever; Fatigue; Joint pain; Rash on right hand (injection in left arm); Immediate pain at injection site, lasting 4 days; Feeling brain fog; Asthma; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administered in arm left, administration date 13Oct2021 (Lot number: FE3590) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: Covid long-hauler, having been diagnosed in Mar202. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 Immunization; Bnt162b2 (Dose: 2), for COVID-19 Immunization. The following information was reported: INJECTION SITE PAIN (non-serious) with onset 13Oct2021, outcome "recovered" (Oct2021), described as "Immediate pain at injection site, lasting 4 days"; PAIN (non-serious) with onset 15Oct2021, outcome "recovered" (Oct2021), described as "Body aches"; PYREXIA (non-serious) with onset 15Oct2021, outcome "recovered" (Oct2021), described as "Fever"; FATIGUE (non-serious) with onset 15Oct2021, outcome "recovered" (Oct2021), described as "Fatigue"; ARTHRALGIA (non-serious) with onset 15Oct2021, outcome "recovered" (Oct2021), described as "Joint pain"; RASH (non-serious) with onset 15Oct2021, outcome "recovered" (Oct2021), described as "Rash on right hand (injection in left arm)"; FEELING ABNORMAL (non-serious) with onset 2021, outcome "unknown", described as "Feeling brain fog"; ASTHMA (non-serious) with onset 2021, outcome "unknown", described as "Asthma". Therapeutic measures were taken as a result of asthma.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Vaccination site pain
Clinical narrative: I started feeling body aches; slight fever; pain in the arm at the vaccine point.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 19Oct2021 06:30 (Lot number: FF2590) as dose 3 (booster dose), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: LIPITOR; BENICAR; INVOKAMET. Past drug history included: Ampicillin. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EP6955, Location of injection: Arm Right), administration date: 19Apr2021, for Covid-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EP6955, Location of injection: Arm Right), administration date: 29Mar2021, for Covid-19 immunization. The following information was reported: PAIN (non-serious) with onset 20Oct2021 17:00, outcome "recovering", described as "I started feeling body aches"; PYREXIA (non-serious) with onset 20Oct2021 17:00, outcome "recovering", described as "slight fever"; VACCINATION SITE PAIN (non-serious) with onset 20Oct2021 17:00, outcome "recovering", described as "pain in the arm at the vaccine point.". Therapeutic measures were not taken as a result of pain, pyrexia, vaccination site pain.  Additional information: Patient didnt have COVID prior vaccination and not tested for COVID after vaccination. Patient signed privacy policy consent and didnt receive any vaccine in other four weeks.  No follow-up attempts are possible. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Dizziness, Headache, Pyrexia
Clinical narrative: dizzy; Rash; Fever 101.8; vomiting; headache; weakness; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient. A 43-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 20Oct2021 11:00 (Lot number: FH2027) at the age of 43 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: NOTES-If Covid prior vaccination: Yes. The patient took concomitant medications. Past drug history included: Ropinirole, reaction(s): "known allergies: Ropinerole". The following information was reported: DIZZINESS (non-serious) with onset 20Oct2021 16:00, outcome "not recovered", described as "dizzy"; RASH (non-serious) with onset 20Oct2021 16:00, outcome "not recovered", described as "Rash"; PYREXIA (non-serious) with onset 20Oct2021 16:00, outcome "not recovered", described as "Fever 101.8"; VOMITING (non-serious) with onset 20Oct2021 16:00, outcome "not recovered", described as "vomiting"; HEADACHE (non-serious) with onset 20Oct2021 16:00, outcome "not recovered", described as "headache"; ASTHENIA (non-serious) with onset 20Oct2021 16:00, outcome "not recovered", described as "weakness". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of dizziness, rash, pyrexia, vomiting, headache, asthenia. Additional information The patient did not receive any other vaccine in four weeks. The patient received other medications in last two weeks.The patient had Covid prior vaccination. The patient had been tested for Covid post vaccination. Covid test type post vaccination was Nasal Swab. Covid test result was Negative  Follow-up attempts are completed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, SARS-CoV-2 test, Vomiting
Clinical narrative: dizzy; Rash; Fever 101.8; vomiting; headache; weakness; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient. A 43-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 20Oct2021 11:00 (Lot number: FH2027) at the age of 43 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: NOTES-If Covid prior vaccination: Yes. The patient took concomitant medications. Past drug history included: Ropinirole, reaction(s): "known allergies: Ropinerole". The following information was reported: DIZZINESS (non-serious) with onset 20Oct2021 16:00, outcome "not recovered", described as "dizzy"; RASH (non-serious) with onset 20Oct2021 16:00, outcome "not recovered", described as "Rash"; PYREXIA (non-serious) with onset 20Oct2021 16:00, outcome "not recovered", described as "Fever 101.8"; VOMITING (non-serious) with onset 20Oct2021 16:00, outcome "not recovered", described as "vomiting"; HEADACHE (non-serious) with onset 20Oct2021 16:00, outcome "not recovered", described as "headache"; ASTHENIA (non-serious) with onset 20Oct2021 16:00, outcome "not recovered", described as "weakness". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of dizziness, rash, pyrexia, vomiting, headache, asthenia. Additional information The patient did not receive any other vaccine in four weeks. The patient received other medications in last two weeks.The patient had Covid prior vaccination. The patient had been tested for Covid post vaccination. Covid test type post vaccination was Nasal Swab. Covid test result was Negative  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Vaccination site pain
Clinical narrative: Body Aches; Fever; Pain in arm where shot received; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient. A 57-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 19Oct2021 18:30 (Lot number: FF2590) as dose 3 (booster), single for covid-19 immunisation. The patient relevant medical history was not reported. Concomitant medication(s) included: LIPITOR; METFORMIN; RYBELSUS. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EP6955, Location of injection: Arm Right), administration date: 19Apr2021, for Covid-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EP6955, Location of injection: Arm Right), administration date: 29Mar2021, for Covid-19 immunization. The following information was reported: PAIN (non-serious) with onset 20Oct2021 17:00, outcome "recovering", described as "Body Aches"; PYREXIA (non-serious) with onset 20Oct2021 17:00, outcome "recovering", described as "Fever"; VACCINATION SITE PAIN (non-serious) with onset 20Oct2021 17:00, outcome "recovering", described as "Pain in arm where shot received". Therapeutic measures were not taken as a result of pain, pyrexia, vaccination site pain. Additional information The patient did not receive any other vaccine in four weeks. The patient received other medications in last two weeks Lipitor, Metformin, Rybelsus. The patient did not have Covid prior vaccination. The patient had not been tested for Covid post vaccination. No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pain, Pyrexia
Clinical narrative: had fevers and aches for about a week up to now; temperature of 101 on and off intermittently through the day/ had fevers and aches for about a week up to now; This is a spontaneous report received from contactable reporter(s) (Physician and Consumer or other non-HCP) from medical information team. A female patient received bnt162b2 (COMIRNATY), administration date Oct2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious) with onset Oct2021, outcome "not recovered", described as "had fevers and aches for about a week up to now"; PYREXIA (non-serious) with onset Oct2021, outcome "not recovered", described as "temperature of 101 on and off intermittently through the day/ had fevers and aches for about a week up to now". Relevant laboratory tests and procedures are available in the appropriate section. Additional information This physician (Patient's husband) reported for a female patient (reporter's wife). Patient History was not Provided. Investigation Assessment was not Provided. Reaction/event as reported by primary source had fevers and aches for about a week up to now and temperature of 101 on and off intermittently through the day. Dates for had fevers and aches for about a week up to now and temperature of 101 on and off intermittently through the day was (From: Unspecified To: Unspecified). Reporter seriousness for temperature of 101 on and off intermittently through the day and had fevers and aches for about a week up to now was Unspecified. Tylenol a Pfizer product was Unspecified, Tylenol manufacturer: Unspecified, Dates for Tylenol: (Start: Unspecified Stop: Unspecified) UPC number of Tylenol: Not Provided, Reason for no lot number: of Tylenol-Caller unwilling to complete the report, Expiry Date of Tylenol was not Provided. Additional Context: Caller states he has a question about possible reactions. His wife got a shot 10 days ago and from Day 4-5 she had fevers and aches for about a week up to now and a temperature of 101 on and off intermittently through the day. Other people are getting reactions and localized redness, this, and that. Is trying to speak to someone to get an idea on what to do or report it. Is asking because they simply can give Tylenol for 2 weeks.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Lymphadenopathy, Nausea, Pyrexia
Clinical narrative: Debilitating headache; Chills; Fever; Lymph node swelling in affected arm pit; Nausea; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient. A 58-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 11Sep2021 09:00 (Lot number: FE3592) at the age of 58 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "High Blood Pressure" (unspecified if ongoing), notes: High Blood Pressure. Concomitant medication(s) included: FLU, administration date 08Sep2021; LOSARTAN; HYDROCHLOROTHIAZIDE. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EH9899, Location of injection: Arm Right, Vaccine Administration Time: 05:00 PM), administration date: 16Dec2020, when the patient was 58 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: EK9231, Location of injection: Arm Right, Vaccine Administration Time: 04:30 PM), administration date: 05Jan2021, when the patient was 58 years old, for Covid-19 immunization. The following information was reported: HEADACHE (non-serious) with onset 11Sep2021 22:00, outcome "recovered" (2021), described as "Debilitating headache"; CHILLS (non-serious) with onset 11Sep2021 22:00, outcome "recovered" (2021), described as "Chills"; PYREXIA (non-serious) with onset 11Sep2021 22:00, outcome "recovered" (2021), described as "Fever"; LYMPHADENOPATHY (non-serious) with onset 11Sep2021 22:00, outcome "recovered" (2021), described as "Lymph node swelling in affected arm pit"; NAUSEA (non-serious) with onset 11Sep2021 22:00, outcome "recovered" (2021), described as "Nausea". Therapeutic measures were not taken as a result of headache, chills, pyrexia, lymphadenopathy, nausea. Additional information The patient received other vaccine in four weeks was FLU SHOT GLAXOSMITHKLINE, lot number 5AJ3B, dose number 1 and vaccine location was Left Arm. The other medications the patient received within 2 weeks of vaccination: Losartan, Hydrochlorothiazide. Worse than previous two covid shots. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not have any Known allergies   No follow-up attempts are possible. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Body temperature, Decreased appetite, Malaise, Pyrexia
Clinical narrative: Friday mid morning temp of 100/low grade fever for 5 days; did not feel well over all; No appetite for 3 days; Stomach ache; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). The reporter is the patient.  A 58 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 14Oct2021 (Lot number: ew0172) at the age of 58 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "High blood pressure" (unspecified if ongoing); "known allergies: penicillin" (unspecified if ongoing); "known allergies: sulfa" (unspecified if ongoing); "known allergies: bee stings" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ej1685), administration date: 22Dec2020, when the patient was 57 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: el3248), administration date: 12Jan2021, when the patient was 57 years old, for Covid-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 15Oct2021, outcome "unknown", described as "Friday mid morning temp of 100/low grade fever for 5 days"; MALAISE (non-serious) with onset 15Oct2021, outcome "unknown", described as "did not feel well over all"; DECREASED APPETITE (non-serious) with onset 15Oct2021, outcome "unknown", described as "No appetite for 3 days"; ABDOMINAL PAIN UPPER (non-serious) with onset 15Oct2021, outcome "unknown", described as "Stomach ache". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, malaise, decreased appetite, abdominal pain upper.  Additional information: No other vaccine received in four weeks. The patient only had issues with the 3rd dose the booster. Received shot on a Thursday afternoon. Friday mid morning temp of 100 did not feel well over all, Temp continued to go up. No appetite for 3 days. Stomach ache and low grade fever for 5 days . No covid prior vaccination. Not tested for covid post vaccination. No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Blood urine present, Migraine, Pyrexia, SARS-CoV-2 test
Clinical narrative: Migraine Has also become more frequent; Within 24 hours of receiving the booster I came down with fever; had clear blood in urine.The bleeding persisted for 4 days before it turned brownish black and stopped.; This is a spontaneous report received from a contactable reporter(s) (Other HCP) via COVID-19 Adverse Event Self-Reporting Solution. The reporter is the patient. A 35 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 22Sep2021 (Lot number: Ew0191) at the age of 35 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL9261, Location of injection: Arm Left), administration date: 26Jan2021, when the patient was 35 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EK9231, Location of injection: Arm Left), administration date: 05Jan2021, when the patient was 34 years old, for Covid-19 immunization.  The following information was reported: PYREXIA (non-serious) with onset Sep2021, outcome "recovered with sequelae", described as "Within 24 hours of receiving the booster I came down with fever"; BLOOD URINE PRESENT (non-serious) with onset Sep2021, outcome "recovered with sequelae", described as "had clear blood in urine.The bleeding persisted for 4 days before it turned brownish black and stopped."; MIGRAINE (non-serious) with onset 27Sep2021, outcome "recovered with sequelae", described as "Migraine Has also become more frequent". The events "within 24 hours of receiving the booster i came down with fever", "had clear blood in urine.the bleeding persisted for 4 days before it turned brownish black and stopped." and "migraine has also become more frequent" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia, blood urine present, migraine.  Additional information: No other vaccine received in four weeks and no other medications in two weeks. No covid prior vaccination. No Known allergies and no other Medical history.  No follow-up attempts are possible. No further information is expected.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever at 101 degrees; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 12 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 21Oct2021 17:00 (Lot number: FH8020) at the age of 12 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Known allergy: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: FLU taken for immunisation, administration date 18Oct2021. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: FF2587, Location of injection: Arm Left, Vaccine Administration Time: 17.00, Route of Administration: Intramuscular), administration date: 30Sep2021, when the patient was 12 years old, for Covid-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 22Oct2021 07:00, outcome "unknown", described as "Fever at 101 degrees". The patient underwent the following laboratory tests and procedures: body temperature: (22Oct2021) 101 degrees. Therapeutic measures were not taken as a result of pyrexia.  Additional information: Other vaccine 4weeks product Flu vaccine was taken. The patient had not covid prior vaccination. The patient had not covid tested post vaccination.    No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Chills, Dysstasia, Fatigue, Middle insomnia
Clinical narrative: I woke up last night, in the middle of the night; Chills/shivering; Fever; body ache; fatigue; hard time even standing; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient. A 52-year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 21Oct2021 10:00 (Lot number: 3203080) at the age of 52 years as dose number unknown (booster), single for covid-19 immunisation. Relevant medical history included: "non-Hodgkin lymphoma" (unspecified if ongoing), notes: Verbatim: Non-Hodgkin lymphoma. The patient took concomitant medications. The following information was reported: MIDDLE INSOMNIA (non-serious) with onset 21Oct2021, outcome "unknown", described as "I woke up last night, in the middle of the night "; CHILLS (non-serious) with onset 21Oct2021, outcome "unknown", described as "Chills/shivering"; PYREXIA (non-serious) with onset 21Oct2021, outcome "unknown", described as "Fever"; PAIN (non-serious) with onset Oct2021, outcome "unknown", described as "body ache"; FATIGUE (non-serious) with onset Oct2021, outcome "unknown", described as "fatigue"; DYSSTASIA (non-serious) with onset Oct2021, outcome "unknown", described as "hard time even standing". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia. Additional information Prior vaccination (4 weeks prior) she waited she want to get flu shot but she did not, wanted to do them after same time so. Other Medications was just vitamins, nothing prescribed. The patient stated that she was just calling to report some side effects. she received the Pfizer Booster yesterday at 10 'o' clock and she felt fine all day, but she woke up last night, in the middle of the night with chills, fever. she was having body ache, fatigue. She was just having hard time even standing. Laboratory Test:, When was my last lab blood work. Last Wednesday I had some blood work done. Treatment for Adverse Events: she did take some Tylenol in the middle of the night because She had a fever. She was shivering at about midnight. Dose for Tylenol It is two 500mg capsule. Yes should we say' the medicine and then two again at 6:30 this morning so half an hour ago back.  No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: I woke up last night, in the middle of the night; Chills/shivering; Fever; body ache; fatigue; hard time even standing; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient. A 52-year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 21Oct2021 10:00 (Lot number: 3203080) at the age of 52 years as dose number unknown (booster), single for covid-19 immunisation. Relevant medical history included: "non-Hodgkin lymphoma" (unspecified if ongoing), notes: Verbatim: Non-Hodgkin lymphoma. The patient took concomitant medications. The following information was reported: MIDDLE INSOMNIA (non-serious) with onset 21Oct2021, outcome "unknown", described as "I woke up last night, in the middle of the night "; CHILLS (non-serious) with onset 21Oct2021, outcome "unknown", described as "Chills/shivering"; PYREXIA (non-serious) with onset 21Oct2021, outcome "unknown", described as "Fever"; PAIN (non-serious) with onset Oct2021, outcome "unknown", described as "body ache"; FATIGUE (non-serious) with onset Oct2021, outcome "unknown", described as "fatigue"; DYSSTASIA (non-serious) with onset Oct2021, outcome "unknown", described as "hard time even standing". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia. Additional information Prior vaccination (4 weeks prior) she waited she want to get flu shot but she did not, wanted to do them after same time so. Other Medications was just vitamins, nothing prescribed. The patient stated that she was just calling to report some side effects. she received the Pfizer Booster yesterday at 10 'o' clock and she felt fine all day, but she woke up last night, in the middle of the night with chills, fever. she was having body ache, fatigue. She was just having hard time even standing. Laboratory Test:, When was my last lab blood work. Last Wednesday I had some blood work done. Treatment for Adverse Events: she did take some Tylenol in the middle of the night because She had a fever. She was shivering at about midnight. Dose for Tylenol It is two 500mg capsule. Yes should we say' the medicine and then two again at 6:30 this morning so half an hour ago back.  No follow-up attempts are possible. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dizziness, Swollen tongue, Tongue discomfort, Tongue pruritus
Clinical narrative: tongue is swollen, it itching and burns; tongue is swollen, it itching and burns; tongue is swollen, it itching and burns; chest hurts; Dizzy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202101427342 (Pfizer). A 45-year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Oct2021 10:10 (Lot number: 320308D) at the age of 45 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: SWOLLEN TONGUE (non-serious), TONGUE DISCOMFORT (non-serious), TONGUE PRURITUS (non-serious) all with onset 22Oct2021 10:40, outcome "unknown" and all described as "tongue is swollen, it itching and burns"; CHEST PAIN (non-serious) with onset 22Oct2021 10:40, outcome "unknown", described as "chest hurts"; DIZZINESS (non-serious) with onset 22Oct2021 10:40, outcome "unknown", described as "Dizzy". Additional information Prior Vaccinations (within 4 weeks) never had any vaccines other than when she was a child. AE(s) following prior vaccinations was none. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) was none. The patient reporting on the Pfizer Covid vaccine and who states she was just forced to take the first dose by her job and now her tongue is swollen, it is itching and burns. Her chest hurts and she feels dizzy. She got the shot about 30 minutes ago and it just started. There was nothing was wrong with her before getting the shot. She wants to report this and know what she is supposed to do. The events did not result in Emergency Room nor Physician Office visit. Relevant Tests was none  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Blood test, Body temperature, Cough, Nausea
Clinical narrative: Restless sleep; I was nauseous; No energy; Dry cough; Had a temperature the day after the shot 99.8.; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 01), for COVID-19 Immunization; Bnt162b2 (Dose: 02), for COVID-19 Immunization. The following information was reported: NAUSEA (non-serious), outcome "recovered", described as "I was nauseous"; ASTHENIA (non-serious), outcome "recovered", described as "No energy"; COUGH (non-serious), outcome "recovered", described as "Dry cough"; PYREXIA (non-serious), outcome "recovered", described as "Had a temperature the day after the shot 99.8."; SLEEP DISORDER (non-serious), outcome "recovered", described as "Restless sleep". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Patient have had a bad week after this 3rd shot. Patient was nauseous. No energy restless sleep. Had a temperature the day after the shot 99.8. Normal temperature is 97.4. It had been a week now, also a dry cough if patient did not drink enough and slightly raised temperature. Today 7 days gone patient felt pretty well, sugar level in normal limits.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.